title: Intrathecal sufentanil (5 vs. 10 microg) for labor analgesia: efficacy and side effects.
abstract: OBJECTIVE
  Despite growing popularity, there are few studies examining the relative efficacy of different doses of intrathecal sufentanil for labor analgesia. This prospective, randomized, double-blind study compared the efficacy and side effects of 5 and 10 microg intrathecal sufentanil.
  
  
  METHODS
  Sixty-three healthy, laboring, term parturients < or =5 cm cervical dilation participated in this study. In a randomized, double-blind fashion, patients received 5 or 10 microg intrathecal sufentanil as part of a combined spinal epidural technique. Patients rated pain, itching, nausea, and sedation on verbal analog scales before and every 10 minutes after drug injection. We also recorded maternal blood pressure and peripheral oxygen saturation before and every 10 minutes after drug injection. Before and 30 and 60 minutes after drug injection, we measured maternal end-tidal CO2.
  
  
  RESULTS
  Both doses of sufentanil provided adequate analgesia. Although 10 microg sufentanil produced slightly more profound analgesia, the duration of pain relief did not differ between the two groups. Both drug doses were associated with significant increases in itching and end-tidal CO2. The 10-microg dose was associated with more sedation and a greater decrease in SaO2.
  
  
  CONCLUSIONS
  Both 5 and 10 microg intrathecal sufentanil provided adequate labor analgesia. Both doses were associated with measurable spinal (itching) and supraspinal (sedation, respiratory depression) side effects.
authors.affiliation: Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
authors.forename: M C
authors.initials: MC
authors.lastname: Norris
authors.forename: S T
authors.initials: ST
authors.lastname: Fogel
authors.forename: B
authors.initials: B
authors.lastname: Holtmann
mesh_terms: D000328:Adult; D016362:Analgesia, Obstetrical; D000701:Analgesics, Opioid / Q000008:administration & dosage*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D011247:Pregnancy; D011446:Prospective Studies; D012119:Respiration / Q000187:drug effects; D017409:Sufentanil / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D000701:Analgesics, Opioid; D017409:Sufentanil